Company intelligence / Profile preview
Jiangxi Kerui Pharmaceutical Co., Ltd.
- Ownership
- Private
- Development stage
- Other
Overview
Jiangxi Kerui Pharmaceutical is an active Chinese pharmaceutical manufacturer focused on innovative small molecule and chemical drug development. Its pipeline includes late-stage influenza antivirals and early-to-mid stage oncology assets targeting KRAS mutations. The company has ongoing clinical trials, with one program at the NDA/BLA stage for influenza and another in Phase 2 for solid tumors with KRAS G12D mutations.[1][4] It operates as a subsidiary under Qingfeng Pharmaceutical Group, one of China's top 100 pharma companies known for its robust innovation platforms.[7]
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Small molecule drugsChemical drugs
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Jiangxi Kerui Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Jiangxi Kerui Pharmaceutical Co., Ltd..